Learn the connection between what you eat and how you feel. Join us each week as licensed nutritionists and dietitians from Nutritional Weight & Wellness share practical, real-life solutions for healthier living through balanced nutrition. For over 25 years, we’ve helped thousands of clients and listeners discover how real food – animal protein, healthy fat, nutrient-dense carbohydrates – can increase energy, stabilize moods, jumpstart metabolism, eliminate cravings, restore digestion, balan ...
…
continue reading
Innhold levert av CureTalks. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av CureTalks eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!
Gå frakoblet med Player FM -appen!
Everything you need to know about Daratumumab and Multiple Myeloma
Manage episode 155045098 series 1143960
Innhold levert av CureTalks. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av CureTalks eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
FDA recently approved daratumumab (Darzalex) to treat patients with multiple myeloma who have received atleast three prior treatments. Daratumumab is the first monoclonal antibody approved for treating myeloma and provides another treatment option for patients who have become resistant to other therapies. Our myeloma panel is talking to the father of daratumumab, Dr. Torben Plesner, on the use of this drug in treating multiple myeloma. Dr. Torben Plesner is Hematologist in the Department of Hematology at Vejle Hospital in Denmark and Professor at the University of Southern Denmark.He has published many peer reviewed articles in high impact journals and his recent research focuses on bone markers and effects of statins on bone markers in multiple myeloma.
…
continue reading
34 episoder
Manage episode 155045098 series 1143960
Innhold levert av CureTalks. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av CureTalks eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
FDA recently approved daratumumab (Darzalex) to treat patients with multiple myeloma who have received atleast three prior treatments. Daratumumab is the first monoclonal antibody approved for treating myeloma and provides another treatment option for patients who have become resistant to other therapies. Our myeloma panel is talking to the father of daratumumab, Dr. Torben Plesner, on the use of this drug in treating multiple myeloma. Dr. Torben Plesner is Hematologist in the Department of Hematology at Vejle Hospital in Denmark and Professor at the University of Southern Denmark.He has published many peer reviewed articles in high impact journals and his recent research focuses on bone markers and effects of statins on bone markers in multiple myeloma.
…
continue reading
34 episoder
Alle episoder
×Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.